Information on the target
The target of this transaction is the Membrane Bioreactor Technology division of MANN+HUMMEL Water & Fluid Solutions GmbH, a leading provider of filtration solutions headquartered in Ludwigsburg, Baden-Württemberg. This division specializes in advanced membrane solutions for both municipal and industrial applications, leveraging the internationally established BIO-CEL technology platform to maintain a strong market position. In the fiscal year 2025, MANN+HUMMEL generated approximately EUR 4.2 billion in revenue, employing an average of 20,371 individuals across more than 80 locations worldwide.
This carve-out transaction allows VTC, a private equity firm, to develop the Membrane Bioreactor Technology division as an independent entity, focusing on sustainable wastewater treatment and water reuse solutions. The strategic intent is to enhance the division's capabilities and market reach in a growing industry.
Industry overview in the target’s specific country
The Sewage Treatment Facilities industry in Germany is characterized by a robust regulatory framework and a strong emphasis on environmental sustainability. With stringent EU directives and national regulations, the industry is undergoing significant transformation to improve efficiency and reduce environmental impact. The demand for advanced wastewater treatment technologies, such as membrane bioreactors, is on the rise as municipalities and industries seek to comply with these regulations while also addressing the increasing scarcity of clean water resources.
Germany's commitment to sustainable development has led to substantial investments in wastewater infrastructure, with a focus on innovative technologies that enhance treatment processes. The integration of membrane bioreactor systems is particularly noteworthy, as these systems offer superior performance in terms of effluent quality and operational efficiency. The market is also witnessing a shift towards decentralized treatment solutions, which cater to smaller communities and industrial applications, further driving growth in the sector.
Moreover, the increasing public awareness regarding water conservation and the need for resource recovery is propelling the adoption of advanced sewage treatment technologies. As a result, companies operating within this space are positioned to benefit from structural megatrends, including the rising demand for clean water and efficient water treatment solutions. The German sewage treatment facilities market is expected to continue expanding, driven by technological advancements and the need for sustainable practices.
The rationale behind the deal The rationale behind the sale of the Membrane Bioreactor Technology division to VTC is rooted in the strategic vision of both MANN+HUMMEL and VTC. For MANN+HUMMEL, this carve-out allows the company to streamline its operations and focus on its core business areas while en…